help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-0443
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Berndt, S.
Right arrow Articles by Foidart, J.-M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berndt, S.
Right arrow Articles by Foidart, J.-M.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 11 4567-4574
Copyright © 2009 by The Endocrine Society

Chorionic Gonadotropin Stimulation of Angiogenesis and Pericyte Recruitment

Sarah Berndt, Silvia Blacher, Sophie Perrier d'Hauterive, Marc Thiry, Marie Tsampalas, André Cruz, Christel Péqueux, Sophie Lorquet, Carine Munaut, Agnès Noël1 and Jean-Michel Foidart1

Laboratory of Tumor and Development Biology (S.Be., S.Bl., A.C., C.P., S.L., C.M., A.N., J.-M.F.), Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer, Center of Immunology (S.P.H., M.Ts.), Laboratory of Cellular Biology (M.Th.), University of Liège, and Department of Obstetrics and Gynecology (S.P.H., S.L., J.-M.F.), Centre Hospitalier Regional, B-4000 Liège, Belgium

Address all correspondence and requests for reprints to: Agnès Noël, Laboratory of Tumor and Developmental Biology, University of Liège, Tour de Pathologie, Centre Hospitalier Universitaire (B23), Sart Tilman, B-4000 Liège, Belgium. E-mail: agnes.noel{at}ulg.ac.be.

Context: During the periimplantation period, human chorionic gonadotropin (hCG) plays a key role by increasing the uterine blood flow through uterine vessel vasodilatation but also through angiogenesis. Indeed, we previously demonstrated that hCG contributes to endothelial cell recruitment and vessel formation.

Objective: In this study, hCG was proposed as an arteriogenic factor that could promote perivascular cell recruitment and vessel stabilization.

Design: The aortic ring assay, a three-dimensional ex vivo angiogenesis system mimicking all the steps of the angiogenesis process was used to study the impact of hCG on pericyte recruitment and vessel maturation.

Setting: The study was conducted at a university hospital laboratory.

Main Outcome Measures: Perivascular cell proliferation, migration, and apposition were quantified by computerized image analysis.

Results: Physiological concentrations of hCG (10–400 IU/ml) significantly enhanced pericyte sprouting and migration and gave rise to the maturation and coverage of endothelial capillaries. In a three-dimensional coculture model of endothelial and perivascular cells, hCG enhanced vessel tube formation and endothelial/mural cell adhesion. In addition, hCG stimulated the proliferation of human umbilical vein endothelial cells and smooth muscle cells. The specificity of these effects was determined by using an anti-hCG blocking antibody. Signaling pathways implicated on this hCG effect is protein kinase A and phospholipase C/protein kinase C dependent for the proliferative effect but only phospholipase C/protein kinase C for the migrative process.

Conclusions: Our findings highlight a novel paracrine role of this early embryonic signal in vessel maturation by stimulating perivascular cell recruitment, migration, and proliferation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society